Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy

International Journal of Nanomedicine

Volumn 11, Issue , 2016, Pages 3475-3485

  Wang, Jun Ying ^a   Chen, Jie ^a   Yang, Jiang ^b   Wang, Hao ^a   Shen, Xiu ^a   Sun, Yuan Ming ^a   Guo, Meili ^c   Zhang, Xiao Dong ^d  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c TIANJIN CHENGJIAN UNIVERSITY   (China)

^d TIANJIN UNIVERSITY   (China)

Author keywords

Cancer therapy; Gold clusters; In vivo toxicity; Long term

Indexed keywords

GLUTATHIONE; GOLD NANOCLUSTER; NANOPARTICLE; UNCLASSIFIED DRUG; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EXCRETION; FEMALE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; RADIOSENSITIZATION; SAFETY; SURFACE CHARGE; TOXICITY; URINARY EXCRETION; UTERINE CERVIX CARCINOMA; ANIMAL; C57BL MOUSE; DRUG EFFECTS; HUMAN; KIDNEY; METABOLISM; NEOPLASM; PATHOLOGY; PLASMA; SURFACE PROPERTY; TISSUE DISTRIBUTION; ULTRASTRUCTURE;

ANIMALS; GLUTATHIONE; GOLD; HUMANS; KIDNEY; MALE; METAL NANOPARTICLES; MICE, INBRED C57BL; NEOPLASMS; PLASMA; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84982690304     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S106073     Document Type: Article

References (61)

1. Zhang XD, Chen J, Luo Z, et al. Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy. Adv Healthcare Mater. 2014;3(1):133–141.
2. Zhang XD, Luo Z, Chen J, et al. Ultrasmall Au10-12(SG)10-12 nanomolecules for high tumor specificity and cancer radiotherapy. Adv Mater. 2014;26(26):4565–4568.
3. Liu J, Yu M, Zhou C, Yang S, Ning X, Zheng J. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. J Am Chem Soc. 2013;135(13):4978–4981.
4. Zhang XD, Wu D, Shen X, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomed. 2011;6:2071–2081.
5. Chen J, Wang H, Long W, et al. Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int J Nanomed. 2013;8:2409–2419.
6. Fernandes R, Smyth NR, Muskens OL, et al. Interactions of skin with gold nanoparticles of different surface charge, shape, and functionality. Small. 2015;11(6):713–721.
7. Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25(10):1165–1170.
8. Zheng J, Zhou C, Yu M, Liu J. Different sized luminescent gold nanoparticles. Nanoscale. 2012;4(14):4073–4083.
9. Zhang XD, Chen J, Yang J, et al. Use of epidermal growth factor receptor antibody–gold cluster conjugates with good renal excretion in targeted cancer radiation treatment. J Mater Chem B. 2015;3(23):4735–4741.
10. Yang Y, Gao N, Hu Y, et al. Gold nanoparticle-enhanced photodynamic therapy: effects of surface charge and mitochondrial targeting. Ther Deliv. 2015;6(3):307–321.
11. Retnakumari A, Setua S, Menon D, et al. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology. 2010;21(5):055103.
12. Zhang X, Wu FG, Liu P, Wang HY, Gu N, Chen Z. Synthesis of ultrastable and multifunctional gold nanoclusters with enhanced fluorescence and potential anticancer drug delivery application. J Colloid Interface Sci. 2015;455:6–15.
13. Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials. 2012;33(27):6408–6419.
14. Zhang XD, Luo Z, Chen J, et al. Storage of gold nanoclusters in muscle leads to their biphasic in vivo clearance. Small. 2015;11(14):1683–1690.
15. Zhou C, Long M, Qin Y, Sun X, Zheng J. Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Ed. 2011;50(14):3168–3172.
16. Shang L, Dong S, Nienhaus GU. Ultra-small fluorescent metal nanoclusters: synthesis and biological applications. Nano Today. 2011;6(4):401–418.
17. Lin CA, Yang TY, Lee CH, et al. Synthesis, characterization, and bioconjugation of fluorescent gold nanoclusters toward biological labeling applications. ACS Nano. 2009;3(2):395–401.
18. Lin Y, Wu Z, Wen J, et al. Adhesion and atomic structures of gold on ceria nanostructures: the role of surface structure and oxidation state of ceria supports. Nano Lett. 2015;15(8):5375–5381.
19. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7(6):1542–1550.
20. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1–16.
21. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134(4):2139–2147.
22. Bozich JS, Lohse SE, Torelli MD, Murphy CJ, Hamers RJ, Klaper RD. Surface chemistry, charge and ligand type impact the toxicity of gold nanoparticles to Daphnia magna. Environ Sci Nano. 2014;1(3):260–270.
23. Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomed. 2010;5:771–781.
24. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small. 2005;1(3):325–327.
25. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005;21(23):10644–10654.
26. Li JJ, Hartono D, Ong CN, Bay BH, Yung LY. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials. 2010;31(23):5996–6003.
27. Ng CT, Li JJ, Gurung RL, et al. Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp Biol Med. 2013;238(12):1355–1361.
28. Li L, Zhang L, Wang T, et al. Facile and scalable synthesis of novel spherical Au nanocluster assemblies@polyacrylic acid/calcium phosphate nanoparticles for dual-modal imaging-guided cancer chemotherapy. Small. 2015;11(26):3162–3173.
29. Chen H, Li S, Li B, et al. Folate-modified gold nanoclusters as near-infrared fluorescent probes for tumor imaging and therapy. Nanoscale. 2012;4(19):6050–6064.
30. Wang HH, Lin CA, Lee CH, et al. Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells. ACS Nano. 2011;5(6):4337–4344.
31. Jenkins JT, Halaney DL, Sokolov KV, et al. Excretion and toxicity of gold–iron nanoparticles. Nanomedicine. 2013;9(3):356–365.
32. Schaeublin NM, Braydich Stolle LK, Schrand AM, et al. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale. 2011;3(2):410–420.
33. Yue ZG, Wei W, Lv PP, et al. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules. 2011;12(7):2440–2446.
34. Asati A, Santra S, Kaittanis C, Perez JM. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 2010;4(9):5321–5331.
35. Shang L, Yang L, Seiter J, et al. Nanoparticles interacting with proteins and cells: a systematic study of protein surface charge effects. Adv Mater Interfaces. 2014;1(2).
36. Calatayud MP, Sanz B, Raffa V, Riggio C, Ibarra MR, Goya GF. The effect of surface charge of functionalized Fe3O4 nanoparticles on protein adsorption and cell uptake. Biomaterials. 2014;35(24):6389–6399.
37. Su GX, Zhou HY, Mu QX, et al. Effective surface charge density determines the electrostatic attraction between nanoparticles and cells. J Phys Chem C. 2012;116(8):4993–4998.
38. Ghosh PS, Kim CK, Han G, Forbes NS, Rotello VM. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano. 2008;2(11):2213–2218.
39. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM. Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol. 2011;45(1):283–287.
40. Souris JS, Lee CH, Cheng SH, et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 2010;31(21):5564–5574.
41. Yuan YY, Mao CQ, Du XJ, Du JZ, Wang F, Wang J. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Adv Mater. 2012;24(40):5476–5480.
42. Frohlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577–5591.
43. Luo Z, Yuan X, Yu Y, et al. From aggregation-induced emission of Au(I)-thiolate complexes to ultrabright Au(0)@Au(I)-thiolate core-shell nanoclusters. J Am Chem Soc. 2012;134(40):16662–16670.
44. Gessner A, Lieske A, Paulke BR, Muller RH. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A. 2003;65(3):319–326.
45. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428–437.
46. Barran-Berdon AL, Pozzi D, Caracciolo G, et al. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir. 2013;29(21):6485–6494.
47. Balogh L, Nigavekar SS, Nair BM, et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine. 2007;3(4):281–296.
48. He CB, Hu YP, Yin LC, Tang C, Yin CH. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–3666.
49. Zhang XD, Yang J, Song SS, et al. Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications. Int J Nanomed. 2014;9:2069–2072.
50. Zhang XD, Wu D, Shen X, Liu PX, Fan FY, Fan SJ. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials. 2012;33(18):4628–4638.
51. Setyawati MI, Tay CY, Chia SL, et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun. 2013;4:1673.
52. Hirn S, Semmler Behnke M, Schleh C, et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm. 2011;77(3):407–416.
53. Xiao K, Li Y, Luo J, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32(13):3435–3446.
54. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008;5(4):505–515.
55. Nigavekar SS, Sung LY, Llanes M, et al. 3H dendrimer nanoparticle organ/tumor distribution. Pharm Res. 2004;21(3):476–483.
56. Yang K, Wan JW, Zhang S, Tian B, Zhang YJ, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials. 2012;33(7):2206–2214.
57. Ishiwata H, Suzuki N, Ando S, Kikuchi H, Kitagawa T. Characteristics and biodistribution of cationic liposomes and their DNA complexes. J Control Release. 2000;69(1):139–148.
58. Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliver Rev. 2011;63(3):136–151.
59. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chem. 2004;15(4):897–900.
60. Zhang E, Fu A. A new strategy for specific imaging of neural cells based on peptide-conjugated gold nanoclusters. Int J Nanomed. 2015;10:2115–2124.
61. Swanner J, Mims J, Carroll DL, et al. Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells. Int J Nanomed. 2015;10:3937–3953.